Bristol Myers Squibb Expands Nvidia Partnership for Biopharma’s Most Powerful Drug-Discovery Supercomputer
Bristol Myers Squibb is expanding a partnership with Nvidia to increase computing power at an artificial intelligence factory designed to accelerate drug discovery.
The expansion will enable the pharmaceutical maker to build the most powerful AI supercomputer in the biopharma sector, making it the first drug company to deploy Nvidia’s latest chips.
From the sources (3 posts)
@businessBristol Myers Squibb is expanding its partnership with Nvidia to boost the computing power of an AI factory that the drugmaker say it’s using to create new medicines more quickly
@endptsBristol Myers Squibb is the latest drugmaker to say it will build biopharma's most powerful AI supercomputer, and will be the first pharma company to use Nvidia's newest chips.
@nerds_xyzBristol Myers Squibb is building a massive NVIDIA AI factory for drug discovery @bmsnews @NVIDIAAI